‍

genOway’s presentation at the Festival of Biologics, Basel 2026

‍

Tuesday, October 13, 2026, 15:10-15:30

‍

Session: Antibodies for Immunotherapy - theatre 8

Presenter: Kader Thiam, CSO & SVP – Discovery, Preclinical Models & Services

Title: "Advancing T‑Cell Engagers: Addressing Key Efficacy and Safety Challenges​"

• Outlining genO-BRGSF-HIS mice: a CD34⁺-reconstituted model with functional human lymphoid and myeloid compartments, without side effects
• Highlighting the key contribution of myeloid cells in the assessment of cytokine release induced by TCE
• Evidencing the recruitment of human immune cells to tumor microenvironment, as well as their activation status

‍

Come visit us at the stand #399!